Science Track Award for Research Transition (START) Program
ID: 360553Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $100K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360553
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Science Track Award for Research Transition (START) Program, aimed at advancing research in substance use disorders (SUDs) and related fields. This grant provides seed funding for innovative projects that intersect substance use research with areas such as the development of new therapeutic interventions, brain imaging techniques, and advanced data science applications. The program is particularly focused on supporting early-stage and new investigators, encouraging them to generate preliminary data that can lead to larger research applications. Interested applicants can reach out to Dr. Hoang Le at hoang.le@nih.gov or call 301-451-8849 for more information. The award ceiling is set at $100,000, with applications expected to be submitted by February 16, 2026, and the estimated award date is December 1, 2026.

    Point(s) of Contact
    Hoang Le, Ph.D.
    (301) 451-8849
    hoang.le@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering the D-START: Data Science Track Award for Research Transition (D/START) under the R03 Small Grant Program, aimed at funding projects that utilize advanced data science techniques to investigate substance use and substance use disorders (SUD). This opportunity encourages new and established researchers to apply innovative methodologies to address critical questions in addiction research, with a focus on small-scale projects that can provide preliminary data for larger studies. The program is particularly designed to foster collaborations from underrepresented groups in STEM and aims to expedite the development of robust research programs in addiction-related data science. Applicants can request budgets of up to $100,000 for a maximum of two years, with a total of six to seven awards available, amounting to $1 million per year for fiscal years 2025 to 2027. Interested parties should submit their applications electronically through Grants.gov by the closing date of September 7, 2027, and can direct inquiries to grantsinfo@nih.gov.
    D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the D-START: Data Science Track Award for Research Transition (D/START), a federal grant aimed at supporting small research projects that utilize advanced data science techniques to address critical issues related to substance use and substance use disorders. This funding opportunity encourages investigators, particularly those newly entering the field or established researchers incorporating novel methodologies, to propose projects that can be executed quickly and efficiently, including pilot studies and secondary analyses of existing datasets. Grants of up to $100,000 per project per year are available for a maximum of two years, with a total of six to seven awards anticipated annually. Interested applicants should adhere to the application guidelines outlined in the NIH Application Guide, with the earliest submission date set for September 16, 2024, and applications due by 5:00 PM local time. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Imaging - Science Track Award for Research Transition (I/START)" aimed at advancing neuroimaging methodologies relevant to substance use disorder (SUD) research. This program encourages both new and established investigators to conduct small "proof-of-concept" studies within a one-year project period, with a funding ceiling of $150,000. The initiative is designed to lower barriers for researchers in adopting advanced imaging techniques, thereby contributing to significant advancements in understanding and addressing substance use challenges. Interested applicants can find more information and application details at the provided link, with the application deadline set for January 7, 2028.
    Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Substance Use/Substance Use Disorder Dissertation Research Award (R36), aimed at supporting doctoral candidates for up to two years in their dissertation research related to substance use disorders. This grant, under the National Institute on Drug Abuse (NIDA), encourages applications from diverse backgrounds and focuses on advancing knowledge in prevention, diagnosis, and treatment of substance misuse and related health outcomes, excluding independent clinical trials. Eligible applicants can receive up to $50,000 per year for innovative research aligned with NIDA’s strategic plan, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support
    National Institutes of Health
    The National Institutes of Health (NIH) is seeking to establish a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through a Cooperative Agreement aimed at enhancing the development of new pharmacotherapeutics for SUD. The Center will focus on educating researchers in formal product development and providing technical and financial support for initial experiments, with an emphasis on creating a product development curriculum and fostering collaborations within the research community. This initiative is crucial for advancing drug addiction research and supporting the translation of innovative concepts into practical applications. The estimated total program funding is $3 million, with one award expected, and interested parties can contact Dr. Tam Nguyen at Tam.Nguyen@nih.gov or (301) 451-1203 for further information. The estimated synopsis post date is November 21, 2025, with applications expected to close on January 27, 2026, and the project anticipated to start on September 1, 2026.
    NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) to support institutional research career development programs aimed at clinician scientists. This grant is designed to provide intensive supervised research training and career development experiences, ultimately leading to research independence in the field of substance use and substance use disorders. The program encourages applications focusing on various scientific areas, including neuroimaging, genetics, medication development, and implementation science, among others. Interested applicants from private institutions of higher education should prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis post date of July 3, 2025, and a close date of August 5, 2025. For further inquiries, applicants can contact Lindsey Friend, Ph.D., at NIDA via email at NIDATraining@nida.nih.gov or by phone at 301-402-1428.
    Avant Garde award for Investigators conducting high risk/high reward research on HIV and Substance Use (or Substance Use Disorders)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce the Avant Garde Award for Investigators conducting high-risk, high-reward research focused on HIV and Substance Use Disorders (SUDs). This grant program aims to support innovative scientists proposing transformative approaches to significant challenges in biomedical and behavioral research related to HIV in the context of substance use. The program particularly encourages early-stage investigators to develop collaborative and impactful research projects, with applications expected to open in March 2026 and close in August 2026. For further inquiries, interested applicants can contact Vasundhara Varthakavi at vasundhara.varthakavi@nih.gov or by phone at 301-443-2146.
    Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)" to support doctoral candidates in completing their dissertation research projects related to substance use disorders. This funding initiative aims to enhance the pool of talented researchers in the field by providing grants of up to $50,000 per year for direct costs over a maximum of two years, with a focus on projects that align with the National Institute on Drug Abuse (NIDA) strategic priorities. Applications are particularly encouraged from individuals who can contribute to diversifying the research workforce, and interested candidates must submit their applications by October 16, 2023, or on February 16 and June 16, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)" aimed at supporting research into effective interventions for substance use disorders (SUDs) and overdose. This cooperative agreement encourages applications for preclinical and clinical studies focusing on pharmacotherapies, device-based treatments, digital therapeutics, and behavioral interventions, with the goal of advancing these interventions towards regulatory approval or clinical adoption. The funding amount can reach up to $3 million, and applications are due by 5:00 PM local time, with multiple submission cycles from October 2025 to August 2028. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity aimed at small business concerns (SBCs) to develop technologies that address health-related social needs impacting substance use disorders (SUD), excluding alcohol use disorder. This initiative, titled "Seeking Products to Address Social Needs impacting SUD," invites applications for Small Business Technology Transfer (STTR) grants under phases I and II, with a total funding amount of $1.3 million available for four awards in FY 2025. The focus is on leveraging innovative technologies, such as telemedicine and mobile health applications, to improve conditions like housing instability and food insecurity that influence SUD outcomes. Interested applicants must comply with specific eligibility criteria and application guidelines, with a submission deadline of March 13, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the full announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-047.html.